SEBIA CAPI 3 CDT-IFCC - HSA Registration DE0505234
Access comprehensive regulatory information for SEBIA CAPI 3 CDT-IFCC in the Singapore medical device market through Pure Global AI's free database. This CLASS B medical device is registered under HSA registration number DE0505234 and owned by SEBIA. The device was registered on December 09, 2020.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The CAPI 3 CDT kit is designed for the separation of the transferrin isoforms in human serum and the quantification of the disialotransferrin fraction ("CDT-IFCC") by capillary electrophoresis in alkaline buffer (pH 8.8) with the CAPILLARYS 3 instrument. CDT (carbohydrate deficient transferrin) is used as a biomarker of chronic moderate to heavy alcohol consumption

